SBTX : Insider Transactions for Silverback Therapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Silverback Therapeutics, Inc. (SBTX)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

173,140,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Silverback Therapeutics is a biopharmaceutical company focused on utilizing its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. Co. has engineered SBT8230 to treat chronic hepatitis B virus by eliciting an anti-viral immune response through targeting TLR8 activation to the liver. SBT8230 is comprised of an ASGR1 monoclonal antibody conjugated to the same TLR8 linker-payload as SBT6050, but with an average drug antibody ratio (DAR) of about two as opposed to the average DAR of about four used in SBT6050.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	1,401,299	1,401,299	8,937,557	8,945,807
Total Buy Value	$13,289,411	$13,289,411	$51,242,891	$51,294,397
Total People Bought	1	1	4	5
Total Buy Transactions	3	3	9	10
Total Shares Sold	1,206,520	1,206,520	1,606,520	1,750,416
Total Sell Value	$11,094,300	$11,094,300	$13,904,016	$14,684,595
Total People Sold	2	2	3	3
Total Sell Transactions	26	26	37	40
End Date	2024-02-15	2023-11-14	2023-05-16	2022-05-16

Adjust Filter Settings

Records found: 118

Page 2 of 5

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Lowenthal Richard E

PRESIDENT AND CEO

• • •

2024-03-13

4

AS

$9.00

$25,200

I/I

(2,800)

2,047,199

-

Tanimoto Sarina

CHIEF MEDICAL OFFICER

• – •

2024-03-13

4

AS

$9.00

$25,200

I/I

(2,800)

2,047,199

-

Lowenthal Richard E

PRESIDENT AND CEO

• • •

2024-02-29

4

AS

$9.01

$34,101

I/I

(3,782)

1,747,447

-

Tanimoto Sarina

CHIEF MEDICAL OFFICER

• – •

2024-02-29

4

AS

$9.01

$34,101

I/I

(3,782)

1,747,447

-

Lowenthal Richard E

PRESIDENT AND CEO

• • •

2024-02-28

4

AS

$9.02

$891,061

I/I

(98,778)

1,748,447

-

Tanimoto Sarina

CHIEF MEDICAL OFFICER

• – •

2024-02-28

4

AS

$9.02

$891,061

I/I

(98,778)

1,748,447

-

Lowenthal Richard E

PRESIDENT AND CEO

• • •

2024-02-26

4

AS

$9.01

$6,307

I/I

(700)

1,772,750

-

Tanimoto Sarina

CHIEF MEDICAL OFFICER

• – •

2024-02-26

4

AS

$9.01

$6,307

I/I

(700)

1,772,750

-

Fitzpatrick Alexander A

Chief Legal Officer

• – –

2023-09-29

4

B

$3.78

$174,994

D/D

46,258

89,227

2.74

-

Fitzpatrick Alexander A

Chief Legal Officer

• – –

2023-09-28

4

B

$3.62

$144,960

D/D

40,000

42,969

2.74

-

Director

– • –

2023-09-21

4

B

$2.97

$8,183,526

I/I

2,700,000

8,556,774

2.1

-

Director

– • –

2023-09-01

4

AS

$7.71

$770,520

D/D

(100,000)

210,346

-

Director

– • –

2023-09-01

4

OE

$1.27

$127,000

D/D

100,000

310,346

-

Orbimed Capital Llc

Director

– • –

2023-08-29

4

B

$6.20

$3,100,000

I/I

500,000

8,019,187

2.1

-

Thompson Peter A

Director

– • –

2023-08-29

4

B

$6.20

$3,100,000

I/I

500,000

8,019,187

2.1

-

Director

– • –

2023-08-29

4

B

$6.20

$23,250,000

I/I

3,750,000

5,856,774

2.1

-

Director

– • –

2023-08-04

4

AS

$7.06

$133,471

D/D

(18,897)

210,346

-

Director

– • –

2023-08-04

4

OE

$1.27

$23,999

D/D

18,897

229,243

-

Director

– • –

2023-08-03

4

AS

$7.01

$183,018

D/D

(26,107)

210,346

-

Director

– • –

2023-08-03

4

OE

$1.27

$33,156

D/D

26,107

236,453

-

Director

– • –

2023-08-02

4

AS

$7.09

$257,265

D/D

(36,281)

210,346

-

Director

– • –

2023-08-02

4

OE

$1.27

$46,077

D/D

36,281

246,627

-

Director

– • –

2023-08-01

4

AS

$7.19

$134,576

D/D

(18,715)

210,346

-

Director

– • –

2023-08-01

4

OE

$1.27

$23,768

D/D

18,715

229,061

-

Director

– • –

2023-07-07

4

AS

$6.36

$56,372

D/D

(8,858)

210,346

-

118 Records found	1 2 3 4 5	Page 2 of 5

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.